Home Cart 0 Sign in  
X

[ CAS No. 30951-66-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 30951-66-7
Chemical Structure| 30951-66-7
Chemical Structure| 30951-66-7
Structure of 30951-66-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 30951-66-7 ]

Related Doc. of [ 30951-66-7 ]

Alternatived Products of [ 30951-66-7 ]

Product Details of [ 30951-66-7 ]

CAS No. :30951-66-7 MDL No. :MFCD11870097
Formula : C9H11BrO Boiling Point : -
Linear Structure Formula :- InChI Key :ZRFMJMFYMQAUDO-UHFFFAOYSA-N
M.W : 215.09 Pubchem ID :15072383
Synonyms :

Calculated chemistry of [ 30951-66-7 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 49.77
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.66 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.44
Log Po/w (XLOGP3) : 2.75
Log Po/w (WLOGP) : 2.57
Log Po/w (MLOGP) : 2.91
Log Po/w (SILICOS-IT) : 2.69
Consensus Log Po/w : 2.67

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.24
Solubility : 0.123 mg/ml ; 0.000571 mol/l
Class : Soluble
Log S (Ali) : -2.83
Solubility : 0.318 mg/ml ; 0.00148 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.5
Solubility : 0.0674 mg/ml ; 0.000313 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.34

Safety of [ 30951-66-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 30951-66-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 30951-66-7 ]
  • Downstream synthetic route of [ 30951-66-7 ]

[ 30951-66-7 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 30951-66-7 ]
  • [ 7073-94-1 ]
Reference: [1] Journal of Organic Chemistry, 1960, vol. 25, # 10, p. 1691 - 1693
  • 2
  • [ 30951-66-7 ]
  • [ 5433-01-2 ]
Reference: [1] Journal of Organic Chemistry, 1972, vol. 37, # 1, p. 126 - 131
  • 3
  • [ 30951-66-7 ]
  • [ 5651-47-8 ]
Reference: [1] Journal of Organic Chemistry, 1972, vol. 37, # 1, p. 126 - 131
  • 4
  • [ 618-89-3 ]
  • [ 75-16-1 ]
  • [ 30951-66-7 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: at 6 - 20℃; for 3.66667 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; diethyl ether; water at 0℃;
EXAMPLE 76; Preparation of N- [ (lS, 2R)-3- { [l- (3-bromophenyl)-l- methylethyl] amino}-1- (3, 5-difluorobenzyl)-2-hydroxypropyl] acetamide; 32 Scheme 8 O Br MeMgBr g NaN3 Br '°H Bu OMe OH Nh THF TFA THF 4 | kOH SOH 4 reflux H 19 H HOH H N, 1) TFA-0 zon F F 0 HCI 2) Ac-Im F 31 3) HCI 30 30 F 31 F NaOH HOH H Bu F 32 Step 1; Preparation of 2- (3-bromophenyl)-2-propanol 27; To 75 mmol of methylmagnesium bromide in 25 mL of ether stirring at 6 °C is added, dropwise over 10 min, a solution of methyl-3-bromobenzoate (4.3 g, 20 mmol) in 25 mL of dry THF. The mixture is then allowed to warm to ambient temperature and stirred for 3.5 h, then cooled to 0°C and quenched by dropwise addition of aqueous 10percent HC1. The acidified mixture is extracted twice with ethyl acetate, and the combined organic phases are washed with 1 N NaHC03 and with brine. The solution is dried over Na2SO4, concentrated, and chromatographed over silica gel, eluting with 15percent ethyl acetate in heptane, to afford 4.00 g (18.6 mmol, 93percent) of 2- (3-bromophenyl)-2- propanol 27 as a pale yellow oil
14.9 g at -78 - 20℃; for 2 h; To a solution of methyl 3-bromobenzoate (15.0 g, 69.8 mmol) in THF (140 mL) at -78 °C was added dropwise a solution of MeMgBr/diethyl ether [3.0M] (58 mL). The reaction mixture was warmed up to room temperature and stirred for 2 h. The solution was poured to an aqueous saturated solution of ammonium chloride and the organic material was extracted with EtOAc. The organic layer was dried over Na2S04, filtered and concentrated to afford the corresponding alcohol (14.9 g) which was used without further purification.
14.9 g at -78 - 20℃; for 2 h; To a solution of methyl 3-bromobenzoate (15.0 g, 69.8 mmol) in THF (140 mL) at −78° C. was added dropwise a solution of MeMgBr/diethyl ether [3.0M] (58 mL). The reaction mixture was warmed up to room temperature and stirred for 2 h. The solution was poured to an aqueous saturated solution of ammonium chloride and the organic material was extracted with EtOAc. The organic layer was dried over Na2SO4, filtered and concentrated to afford the corresponding alcohol (14.9 g) which was used without further purification.
Reference: [1] Patent: WO2005/95326, 2005, A2, . Location in patent: Page/Page column 189-190
[2] Journal of Organic Chemistry, 1960, vol. 25, # 10, p. 1691 - 1693
[3] Patent: WO2005/70932, 2005, A2, . Location in patent: Page/Page column 51
[4] Patent: WO2015/89067, 2015, A1, . Location in patent: Page/Page column 122
[5] Patent: US9126993, 2015, B2, . Location in patent: Page/Page column 50
  • 5
  • [ 75-16-1 ]
  • [ 2142-63-4 ]
  • [ 30951-66-7 ]
YieldReaction ConditionsOperation in experiment
90% at 0 - 20℃; for 4 h; A solution of 3N METHYLMAGNESIUM bromide (6.53 mL, 19.59 mmol, 3 eq) in diethyl ether was cooled to 0 °C and treated with 3-bromoacetophenone (1.3 g, 6.53 MMOL). The reaction was stirred at room temperature for 4 h. The reaction was diluted with ethyl acetate and water. The layers were separated and the organic was washed with saturated sodium bicarbonate, 2N HCI, brine and dried over magnesium sulfate. The solvent was removed at reduced pressure and purified on the MPLC (Biotage) eluted with 5-10percent ethyl acetate-hexane to afford 1.2 g (90 percent) of the product. Rf = 0.22 (silica, ethyl acetate: hexanes, 1: 9) ; H-NMR (DMSO-D6) 8 7.63 (t, J = 1.8 Hz, 1H), 7.45 to 7.35 (m, 2H), 7.25 (t, J = 7.7, 1H), 5.15 (s, 1H), 1.39 (s, 6H).
90%
Stage #1: at 0 - 20℃; for 4 h;
Stage #2: With water In diethyl ether; ethyl acetate
Example 22; Method H-15; Preparation of 2-(3-Bromo-phenyl)-propan-2-ol; A solution of 3N methylmagnesium bromide (6.53 mL, 19.59 mmol, 3 eq) in diethyl ether was cooled to 0 °C and treated with3-bromoacetophenone (1.3 g, 6.53 mmol). The reaction was stirred at room temperature for 4 h. The reaction was diluted with ethyl acetate and water. The layers were separated and the organic was washed with saturated sodium bicarbonate, 2N HCI, brine and dried over magnesium sulfate. The solvent was removed at reduced pressure and purified on the MPLC (Biotage) eluted with 5-10percent ethyl acetate-hexane to afford 1.2 g (90 percent) of the product. Rf = 0.22 (silica, ethyl acetate: hexanes, 1: 9) ; 1H-NMR (DMSO-d6) 6 7.63 (t, J = 1.8 Hz, 1H), 7.45 to 7.35 (m, 2H), 7.25 (t, J = 7. 7, 1H), 5.15 (s, 1H), 1.39 (s, 6H).
90%
Stage #1: at 0℃; for 4 h;
Stage #2: With water In diethyl ether; ethyl acetate
Preparation of 2-(3-Bromo-phenvl)-propan-2-ol. A solution of 3N methylmagnesium bromide (6.53 mL, 19.59 mmol, 3 eq) in diethyl ether was cooled to 0 0C and treated with3-bromoacetophenone (1.3 g, 6.53 mmol). The reaction was stirred at room temperature for 4 h. The reaction was diluted with ethyl acetate and water. The layers were separated and the organic was washed with saturated sodium bicarbonate, 2N HCl, brine and dried over magnesium sulfate. The solvent was removed at reduced pressure and purified on theMPLC (Biotage) eluted with 5-10percent ethyl acetate - hexane to afford 1.2 g (90 percent) of the product. Rf = 0.22 (silica, ethyl acetate:hexanes, 1:9); 1H-NMR (DMSO-d6) 7.63 (t, J = 1.8 Hz, IH), 7.45 to 7.35 (m, 2H), 7.25 (t, J = 7.7, IH), 5.15 (s, IH), 1.39 (s, 6H).
Reference: [1] Organic Letters, 2017, vol. 19, # 23, p. 6332 - 6335
[2] Patent: WO2005/14566, 2005, A1, . Location in patent: Page/Page column 103
[3] Patent: WO2003/72561, 2003, A1, . Location in patent: Page/Page column 27
[4] Patent: WO2008/25509, 2008, A1, . Location in patent: Page/Page column 50
[5] Tetrahedron Letters, 2007, vol. 48, # 28, p. 4825 - 4829
[6] Patent: US2011/65745, 2011, A1, . Location in patent: Page/Page column 8
[7] Patent: US2011/65727, 2011, A1, . Location in patent: Page/Page column 15-16
  • 6
  • [ 917-64-6 ]
  • [ 2142-63-4 ]
  • [ 30951-66-7 ]
Reference: [1] Journal of the American Chemical Society, 1982, vol. 104, # 15, p. 4173 - 4179
[2] Patent: US2007/254892, 2007, A1, . Location in patent: Page/Page column 42
[3] Chemical Communications, 2011, vol. 47, # 13, p. 3989 - 3991
  • 7
  • [ 618-89-3 ]
  • [ 74-88-4 ]
  • [ 30951-66-7 ]
YieldReaction ConditionsOperation in experiment
4.98 g
Stage #1: With magnesium In diethyl etherReflux
Stage #2: for 3 h; Reflux
A solution of methylmagnesium iodide is prepared from 5.79 ml of methyl iodide and 2.2 g of magnesium turnings in refluxing ether. A solution of 5 g of methyl 3- bromobenzoate in 110 ml of ether is then added dropwise and the mixture is refluxed for 3 hours. The reaction mixture is poured onto ice/saturated NH4C1, the phases are separated by settling, the organic phase is washed with 10percent aHC03 solution and with saturated NaCl solution, and dried over MgS04, and the solvent is evaporated off under vacuum. 4.98 g of the expected compound are obtained.
Reference: [1] Patent: WO2013/87643, 2013, A1, . Location in patent: Page/Page column 15
  • 8
  • [ 1711-09-7 ]
  • [ 30951-66-7 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 5380,5383
[2] Journal of the American Chemical Society, 1955, vol. 77, p. 3763,3764
  • 9
  • [ 24398-88-7 ]
  • [ 30951-66-7 ]
Reference: [1] Journal of the American Chemical Society, 1957, vol. 79, p. 1906,1909
  • 10
  • [ 2142-63-4 ]
  • [ 30951-66-7 ]
Reference: [1] Journal of Organic Chemistry, 2012, vol. 77, # 7, p. 3127 - 3133
  • 11
  • [ 585-76-2 ]
  • [ 30951-66-7 ]
Reference: [1] Chinese Chemical Letters, 2011, vol. 22, # 10, p. 1215 - 1218
  • 12
  • [ 24398-88-7 ]
  • [ 676-58-4 ]
  • [ 30951-66-7 ]
Reference: [1] Chinese Chemical Letters, 2011, vol. 22, # 10, p. 1215 - 1218
  • 13
  • [ 30951-66-7 ]
  • [ 955369-43-4 ]
Reference: [1] Patent: US2007/254892, 2007, A1, . Location in patent: Page/Page column 42
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 30951-66-7 ]

Aryls

Chemical Structure| 7073-69-0

[ 7073-69-0 ]

2-(2-Bromophenyl)propan-2-ol

Similarity: 0.98

Chemical Structure| 2077-19-2

[ 2077-19-2 ]

2-(4-Bromophenyl)propan-2-ol

Similarity: 0.97

Chemical Structure| 134615-22-8

[ 134615-22-8 ]

(S)-1-(3-Bromophenyl)ethanol

Similarity: 0.95

Chemical Structure| 109240-30-4

[ 109240-30-4 ]

1-(4-Bromophenyl)cyclopropanol

Similarity: 0.93

Chemical Structure| 100760-04-1

[ 100760-04-1 ]

(S)-1-(4-Bromophenyl)ethanol

Similarity: 0.92

Bromides

Chemical Structure| 7073-69-0

[ 7073-69-0 ]

2-(2-Bromophenyl)propan-2-ol

Similarity: 0.98

Chemical Structure| 2077-19-2

[ 2077-19-2 ]

2-(4-Bromophenyl)propan-2-ol

Similarity: 0.97

Chemical Structure| 134615-22-8

[ 134615-22-8 ]

(S)-1-(3-Bromophenyl)ethanol

Similarity: 0.95

Chemical Structure| 109240-30-4

[ 109240-30-4 ]

1-(4-Bromophenyl)cyclopropanol

Similarity: 0.93

Chemical Structure| 100760-04-1

[ 100760-04-1 ]

(S)-1-(4-Bromophenyl)ethanol

Similarity: 0.92

Alcohols

Chemical Structure| 7073-69-0

[ 7073-69-0 ]

2-(2-Bromophenyl)propan-2-ol

Similarity: 0.98

Chemical Structure| 2077-19-2

[ 2077-19-2 ]

2-(4-Bromophenyl)propan-2-ol

Similarity: 0.97

Chemical Structure| 134615-22-8

[ 134615-22-8 ]

(S)-1-(3-Bromophenyl)ethanol

Similarity: 0.95

Chemical Structure| 109240-30-4

[ 109240-30-4 ]

1-(4-Bromophenyl)cyclopropanol

Similarity: 0.93

Chemical Structure| 100760-04-1

[ 100760-04-1 ]

(S)-1-(4-Bromophenyl)ethanol

Similarity: 0.92